article thumbnail

Public Health Product Hops

Bill of Health

Yet Dmitry Karshtedt held otherwise at the ASLME Health Law Professor’s Conference in Atlanta, GA in 2017. My latest article, Public Health Product Hops (forthcoming 2023, American University Law Review, available on SSRN ), represented my long-form attempt to reconcile our differing opinions on product hopping.

article thumbnail

The Privatization of Cancer

Bill of Health

In fact, the majority of Americans do not hold strong trust in our health agencies like FDA and CDC. In my forthcoming article, I argue that our cancer regulatory regimes inadequately protect the public. The Privatization of Cancer Privatization is the transfer of public power to private hands. In 2017, 72% of U.S.

FDA 301
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

EU and US Regulatory Challenges Facing AI Health Care Innovator Firms

Bill of Health

Beyond the health care sector-specific Medical Devices Regulation (EU) 2017/745 (MDR) and the In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR), this mix of AI & Data related regulatory requirements stems from a series of generalized, cross-sectoral EU laws of the last 5 years.

FDA 282
article thumbnail

False and Deceptive Health Claims: Buyers Beware

Bill of Health

The FDA’s primary responsibility is over claims that appear on product labels (including packaging, product inserts, and promotional material at the point of sale), and the FTC regulates claims made in advertising in general. FDA regulations prescribe different standards for different products and claims. million to consumers.

FDA 184
article thumbnail

AI’s Ability to Manipulate Decision Making Requires a Moratorium on Its Use in Obtaining Consent for Biomedical Research

Bill of Health

Public Health Service’s (USPHS) Syphilis Study at Tuskegee , whose revelation to the public sparked today’s legal schema for regulating and protecting the research it funds (the “Common Rule”), as well as research done in anticipation of receiving FDA approval for marketing a new product. While the U.S.

article thumbnail

Cerner CEO pledges to zero-out 'noise' from EHRs, population health and revenue cycle

Healthcare It News

"In 2017, gene therapy was used to cure a teenage boy of sickle cell disease," he said. "That same year, FDA approved smart pills. "COVID-19 showed the world what's wrong: Not enough focus on public health, prevention and equity. They alert users if they've already taken their medication.

article thumbnail

IoT and The Rise of the Machines in Healthcare

Health Populi

. “During the chaos and confusion, threat actors launched cyberattacks,” Ordr observed in the wake of the public health crisis. In this Rise of the Medical Machines, the major risks for health care organizations were that, 68% of health care deployments had more than 10 FDA recalls. billion.

COVID-19 174